Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OASIS-HT: Rostafuroxin Dose-Finding in Essential Hypertension
NCT00415038Phase 2Completed
- Sponsor
- Sigma-Tau
- Start
- Feb 2005
- Primary completion
- Apr 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of rostafuroxin in essential hypertension, sponsored by Sigma-Tau. Started Feb 2005; status: completed.
02
Drugs
rostafuroxin
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT00415038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00415038.